Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)

OBJECTIVE: To compare the efficacy and safety between tocilizumab added to methotrexate and tocilizumab switched from methotrexate in patients with active rheumatoid arthritis (RA). METHODS: This is a 2-year randomised, controlled study. RA patients with moderate or high disease activity despite met...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneko, Yuko, Atsumi, Tatsuya, Tanaka, Yoshiya, Inoo, Masayuki, Kobayashi-Haraoka, Hitomi, Amano, Koichi, Miyata, Masayuki, Murakawa, Yohko, Yasuoka, Hidekata, Hirata, Shintaro, Nagasawa, Hayato, Tanaka, Eiichi, Miyasaka, Nobuyuki, Yamanaka, Hisashi, Yamamoto, Kazuhiko, Takeuchi, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099201/
https://www.ncbi.nlm.nih.gov/pubmed/26733110
http://dx.doi.org/10.1136/annrheumdis-2015-208426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099201/
https://www.ncbi.nlm.nih.gov/pubmed/26733110
http://dx.doi.org/10.1136/annrheumdis-2015-208426

Ejemplares similares